Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 24 | 2024 | 318 | 6.330 |
Why?
|
| Infant, Premature | 12 | 2024 | 812 | 2.950 |
Why?
|
| Infant, Premature, Diseases | 7 | 2024 | 239 | 2.210 |
Why?
|
| Infant, Newborn | 50 | 2024 | 8172 | 2.040 |
Why?
|
| Infant, Extremely Premature | 8 | 2024 | 84 | 1.680 |
Why?
|
| Hypoxia-Ischemia, Brain | 9 | 2024 | 80 | 1.680 |
Why?
|
| Noise | 2 | 2023 | 19 | 1.550 |
Why?
|
| Erythropoietin | 6 | 2022 | 105 | 1.390 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2021 | 171 | 1.290 |
Why?
|
| Gestational Age | 13 | 2024 | 1161 | 1.240 |
Why?
|
| Child Development | 3 | 2023 | 266 | 1.110 |
Why?
|
| Lung Diseases | 2 | 2022 | 383 | 1.060 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2021 | 314 | 1.040 |
Why?
|
| Bronchopulmonary Dysplasia | 4 | 2023 | 190 | 1.010 |
Why?
|
| Heart Arrest | 2 | 2021 | 350 | 1.000 |
Why?
|
| Hypothermia, Induced | 6 | 2024 | 162 | 0.980 |
Why?
|
| Hypoglycemia | 3 | 2021 | 193 | 0.860 |
Why?
|
| Anticonvulsants | 2 | 2024 | 377 | 0.800 |
Why?
|
| Tocolytic Agents | 1 | 2022 | 12 | 0.790 |
Why?
|
| Needs Assessment | 1 | 2023 | 176 | 0.770 |
Why?
|
| Phenobarbital | 1 | 2021 | 36 | 0.760 |
Why?
|
| Parents | 4 | 2021 | 1039 | 0.740 |
Why?
|
| Infant | 23 | 2024 | 12454 | 0.740 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2023 | 170 | 0.720 |
Why?
|
| Papaver | 1 | 2020 | 3 | 0.710 |
Why?
|
| Incubators, Infant | 1 | 2020 | 4 | 0.710 |
Why?
|
| Visitors to Patients | 1 | 2020 | 9 | 0.710 |
Why?
|
| Hospital Administration | 1 | 2020 | 24 | 0.710 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 17 | 0.700 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.680 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 54 | 0.670 |
Why?
|
| Neuroprotection | 1 | 2019 | 26 | 0.660 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 57 | 0.660 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2023 | 446 | 0.660 |
Why?
|
| Infection Control | 1 | 2020 | 160 | 0.640 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 38 | 0.630 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 339 | 0.620 |
Why?
|
| Hypernatremia | 1 | 2019 | 29 | 0.610 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 240 | 0.610 |
Why?
|
| Hyponatremia | 1 | 2019 | 72 | 0.600 |
Why?
|
| Epoprostenol | 1 | 2018 | 67 | 0.590 |
Why?
|
| Sodium | 1 | 2019 | 294 | 0.580 |
Why?
|
| Humans | 52 | 2024 | 124231 | 0.580 |
Why?
|
| United States | 12 | 2024 | 10754 | 0.560 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 190 | 0.560 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2018 | 89 | 0.560 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 204 | 0.550 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.540 |
Why?
|
| Retrospective Studies | 14 | 2024 | 16208 | 0.510 |
Why?
|
| Nitric Oxide | 2 | 2018 | 449 | 0.510 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 609 | 0.500 |
Why?
|
| Resuscitation | 1 | 2017 | 245 | 0.480 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 357 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 373 | 0.480 |
Why?
|
| Mass Screening | 1 | 2020 | 786 | 0.470 |
Why?
|
| Hemorrhage | 1 | 2018 | 458 | 0.460 |
Why?
|
| Hypothermia | 2 | 2023 | 55 | 0.410 |
Why?
|
| Pandemics | 1 | 2020 | 1101 | 0.410 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3410 | 0.410 |
Why?
|
| Milk, Human | 3 | 2021 | 301 | 0.400 |
Why?
|
| Female | 27 | 2024 | 66254 | 0.390 |
Why?
|
| Salmonella typhi | 1 | 2011 | 16 | 0.380 |
Why?
|
| Typhoid Fever | 1 | 2011 | 19 | 0.380 |
Why?
|
| Retinopathy of Prematurity | 2 | 2024 | 56 | 0.370 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3710 | 0.360 |
Why?
|
| Infant, Low Birth Weight | 3 | 2021 | 168 | 0.360 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 134 | 0.350 |
Why?
|
| Pregnancy | 9 | 2024 | 7238 | 0.330 |
Why?
|
| Dietary Supplements | 4 | 2024 | 477 | 0.290 |
Why?
|
| Premature Birth | 2 | 2022 | 385 | 0.260 |
Why?
|
| Male | 19 | 2024 | 60871 | 0.260 |
Why?
|
| Patient Selection | 2 | 2021 | 687 | 0.260 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 80 | 0.250 |
Why?
|
| Decision Making | 2 | 2021 | 654 | 0.240 |
Why?
|
| Electroencephalography | 3 | 2024 | 868 | 0.230 |
Why?
|
| Seizures | 3 | 2024 | 877 | 0.220 |
Why?
|
| Incubators | 1 | 2023 | 2 | 0.220 |
Why?
|
| Sound | 1 | 2023 | 21 | 0.220 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 72 | 0.210 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 91 | 0.210 |
Why?
|
| Birth Weight | 3 | 2022 | 348 | 0.210 |
Why?
|
| Weight Gain | 2 | 2023 | 404 | 0.210 |
Why?
|
| Vitamin D | 1 | 2024 | 160 | 0.210 |
Why?
|
| Oximetry | 1 | 2024 | 162 | 0.210 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2009 | 382 | 0.210 |
Why?
|
| Neonatology | 1 | 2023 | 51 | 0.210 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2002 | 33 | 0.210 |
Why?
|
| Palivizumab | 1 | 2022 | 46 | 0.200 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 96 | 0.200 |
Why?
|
| Tocolysis | 1 | 2022 | 5 | 0.200 |
Why?
|
| Status Epilepticus | 1 | 2023 | 144 | 0.190 |
Why?
|
| Administration, Intravenous | 2 | 2022 | 143 | 0.190 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2022 | 72 | 0.190 |
Why?
|
| Magnesium Sulfate | 1 | 2022 | 50 | 0.190 |
Why?
|
| Phenytoin | 1 | 2021 | 64 | 0.190 |
Why?
|
| Breast Feeding | 2 | 2021 | 220 | 0.190 |
Why?
|
| Refusal to Participate | 1 | 2021 | 2 | 0.180 |
Why?
|
| Texas | 2 | 2020 | 3586 | 0.180 |
Why?
|
| Placenta Diseases | 1 | 2021 | 58 | 0.180 |
Why?
|
| Parental Consent | 1 | 2021 | 23 | 0.180 |
Why?
|
| Hospital Design and Construction | 1 | 2020 | 8 | 0.180 |
Why?
|
| Patients' Rooms | 1 | 2020 | 9 | 0.180 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 156 | 0.180 |
Why?
|
| Tea | 1 | 2020 | 15 | 0.180 |
Why?
|
| Probiotics | 1 | 2023 | 209 | 0.180 |
Why?
|
| Equipment Safety | 1 | 2020 | 37 | 0.180 |
Why?
|
| Infant Health | 1 | 2020 | 16 | 0.180 |
Why?
|
| Cholestasis | 1 | 2022 | 150 | 0.180 |
Why?
|
| Policy Making | 1 | 2020 | 59 | 0.170 |
Why?
|
| Organizational Policy | 1 | 2020 | 54 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 552 | 0.170 |
Why?
|
| Codeine | 1 | 2020 | 24 | 0.170 |
Why?
|
| Echoencephalography | 1 | 2020 | 25 | 0.170 |
Why?
|
| Seeds | 1 | 2020 | 42 | 0.170 |
Why?
|
| Morphine | 1 | 2020 | 88 | 0.170 |
Why?
|
| Drug Evaluation | 1 | 2019 | 111 | 0.170 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2019 | 2 | 0.170 |
Why?
|
| Rhombencephalon | 2 | 2009 | 46 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 145 | 0.160 |
Why?
|
| Manikins | 1 | 2020 | 134 | 0.160 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 23 | 0.160 |
Why?
|
| Pregnancy, Multiple | 1 | 2019 | 50 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 169 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 308 | 0.150 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 82 | 0.150 |
Why?
|
| Child, Preschool | 6 | 2024 | 14043 | 0.150 |
Why?
|
| Eye Diseases | 1 | 2019 | 113 | 0.150 |
Why?
|
| Eating | 1 | 2020 | 373 | 0.150 |
Why?
|
| Food, Fortified | 1 | 2018 | 96 | 0.150 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 180 | 0.150 |
Why?
|
| Pulmonary Surfactants | 1 | 2018 | 43 | 0.150 |
Why?
|
| Prevalence | 2 | 2022 | 2427 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 292 | 0.140 |
Why?
|
| Phospholipids | 1 | 2018 | 107 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2020 | 339 | 0.140 |
Why?
|
| Double-Blind Method | 4 | 2022 | 1614 | 0.140 |
Why?
|
| Hospitals | 1 | 2020 | 395 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2022 | 746 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 252 | 0.140 |
Why?
|
| Infant Mortality | 1 | 2018 | 174 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2023 | 4725 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 402 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1086 | 0.130 |
Why?
|
| Biological Products | 1 | 2018 | 117 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 763 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 316 | 0.130 |
Why?
|
| Liver | 1 | 2002 | 1753 | 0.120 |
Why?
|
| Child | 4 | 2024 | 24466 | 0.120 |
Why?
|
| Informed Consent | 1 | 2018 | 342 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 624 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2021 | 519 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1522 | 0.120 |
Why?
|
| Glucose | 1 | 2019 | 886 | 0.120 |
Why?
|
| Logistic Models | 1 | 2019 | 1801 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 504 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 1131 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1174 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 1268 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 717 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 1752 | 0.110 |
Why?
|
| Epilepsy | 1 | 2021 | 867 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2019 | 713 | 0.110 |
Why?
|
| Biomarkers | 2 | 2020 | 2972 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3257 | 0.100 |
Why?
|
| Pakistan | 1 | 2011 | 77 | 0.090 |
Why?
|
| Proprioception | 1 | 2009 | 20 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 55 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1813 | 0.080 |
Why?
|
| Arousal | 1 | 2009 | 81 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12260 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2884 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 75 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 6252 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2008 | 212 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1423 | 0.070 |
Why?
|
| Interneurons | 1 | 2008 | 142 | 0.070 |
Why?
|
| Risk Factors | 3 | 2022 | 10118 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2008 | 304 | 0.070 |
Why?
|
| Brain | 3 | 2024 | 3001 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 1096 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 6086 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 702 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2024 | 286 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2009 | 3755 | 0.050 |
Why?
|
| Hemochromatosis Protein | 1 | 2002 | 22 | 0.050 |
Why?
|
| Asphyxia | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hepcidins | 1 | 2002 | 20 | 0.050 |
Why?
|
| Olive Oil | 1 | 2022 | 22 | 0.050 |
Why?
|
| Neurons | 2 | 2009 | 1971 | 0.050 |
Why?
|
| Indomethacin | 1 | 2022 | 84 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2022 | 66 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 88 | 0.050 |
Why?
|
| Albuminuria | 1 | 2022 | 92 | 0.050 |
Why?
|
| Fish Oils | 1 | 2022 | 83 | 0.050 |
Why?
|
| Spleen | 1 | 2002 | 280 | 0.050 |
Why?
|
| Bilirubin | 1 | 2022 | 122 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3572 | 0.050 |
Why?
|
| Hydrops Fetalis | 1 | 2021 | 75 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5094 | 0.040 |
Why?
|
| Trust | 1 | 2021 | 75 | 0.040 |
Why?
|
| Administration, Buccal | 1 | 2019 | 4 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 254 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 267 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 567 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 64 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2019 | 63 | 0.040 |
Why?
|
| Pacifiers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 72 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2009 | 200 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 203 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 1098 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 426 | 0.040 |
Why?
|
| Vomiting | 1 | 2018 | 115 | 0.040 |
Why?
|
| Acidosis | 1 | 2018 | 94 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 209 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 723 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 494 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 17739 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2021 | 1182 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2019 | 247 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 586 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1688 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 377 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 347 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 454 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2821 | 0.030 |
Why?
|
| Cell Movement | 2 | 2009 | 835 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 950 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2416 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 1411 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 34134 | 0.030 |
Why?
|
| Hypoventilation | 1 | 2009 | 13 | 0.020 |
Why?
|
| Auditory Pathways | 1 | 2009 | 19 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 22 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2009 | 35 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 58 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 71 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 82 | 0.020 |
Why?
|
| Levodopa | 1 | 2009 | 91 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2008 | 40 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 392 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 969 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 471 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2009 | 266 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2009 | 195 | 0.020 |
Why?
|
| Nerve Net | 1 | 2009 | 239 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 542 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 997 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 29350 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 2603 | 0.010 |
Why?
|